MannKind Corporation
High capacity diketopiperazine microparticles and methods
Last updated:
Abstract:
Disclosed herein are diketopiperazine microparticles having high capacity for adsorbing a drug or active agent. In particular, the diketopiperazine microparticle are formed using fumaryl diketopiperazine and can comprise a drug in large doses for the treatment of disease or disorders by pulmonary delivery via oral inhalation.
Status:
Grant
Type:
Utility
Filling date:
10 Jan 2020
Issue date:
6 Sep 2022